Mark A Knepper Selected Research

Carcinoma (Carcinomatosis)

7/2007

Identification and quantification of basic and acidic proteins using solution-based two-dimensional protein fractionation and label-free or 18O-labeling mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Knepper Research Topics

Disease

16	Polyuria 01/2019 - 01/2002
11	Nephrogenic Diabetes Insipidus 01/2021 - 12/2003
10	Ureteral Obstruction 07/2011 - 05/2003
7	Hypertension (High Blood Pressure) 05/2015 - 06/2002
5	Hyponatremia 01/2018 - 02/2001
4	Kidney Diseases (Kidney Disease) 03/2014 - 06/2008
4	Heart Failure 02/2014 - 01/2002
4	Fibrosis (Cirrhosis) 02/2014 - 02/2005
4	Ascites 03/2006 - 05/2004
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 06/2002
3	Hypercalcemia (Milk Alkali Syndrome) 03/2004 - 01/2002
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 09/2004
2	Inappropriate ADH Syndrome (SIADH) 01/2018 - 01/2002
2	Hypokalemia 12/2012 - 06/2006
2	Polydipsia 10/2009 - 06/2006
2	Bartter Syndrome (Syndrome, Bartter) 02/2009 - 09/2004
2	Hydronephrosis 11/2008 - 06/2004
2	Gitelman Syndrome 06/2006 - 09/2004
2	Nephrotic Syndrome (Syndrome, Nephrotic) 03/2006 - 05/2004
2	Proteinuria 03/2006 - 05/2004
2	Hypoalbuminemia 03/2006 - 05/2004
2	Edema (Dropsy) 03/2006 - 05/2004
2	Diabetes Insipidus 02/2006 - 11/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2005 - 02/2005
2	Hyperaldosteronism (Conn Syndrome) 02/2005 - 11/2003
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Albuminuria 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Wounds and Injuries (Trauma) 09/2014
1	Necrosis 04/2014
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 02/2014
1	Inflammation (Inflammations) 12/2012
1	Epilepsy (Aura) 05/2009
1	Alkalosis 05/2009
1	Deafness (Deaf Mutism) 05/2009
1	Ataxia (Dyssynergia) 05/2009
1	Atrophy 11/2008
1	Type 2 Diabetes Mellitus (MODY) 12/2007
1	Hyperglycemia 12/2007
1	Osteoporosis 09/2007
1	Carcinoma (Carcinomatosis) 07/2007
1	Hypertrophy 06/2007
1	Acidosis 01/2007
1	Paralysis (Palsy) 04/2006

Drug/Important Bio-Agent (IBA)

19	SodiumIBA 02/2009 - 02/2001
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
12	Vasopressins (Vasopressin)IBA 01/2021 - 02/2001
11	Aquaporins (Water Channels)IBA 01/2018 - 12/2002
10	LithiumIBA 01/2021 - 12/2003
10	Aquaporin 2IBA 01/2019 - 05/2003
7	AldosteroneIBA 06/2006 - 12/2002
6	SaltsIBA 01/2019 - 06/2002
6	Epithelial Sodium ChannelsIBA 12/2007 - 05/2003
4	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2017 - 01/2004
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2008
3	ThiazidesIBA 09/2007 - 11/2004
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 06/2004
2	ProteomeIBA 01/2018 - 06/2008
2	DiureticsIBA 05/2015 - 06/2007
2	Pharmaceutical PreparationsIBA 09/2014 - 09/2007
2	AntibodiesIBA 03/2014 - 02/2005
2	Angiotensin IIIBA 12/2009 - 05/2003
2	Antidiuretic AgentsIBA 04/2008 - 11/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2008 - 11/2006
2	candesartanIBA 11/2006 - 05/2003
2	SymportersIBA 11/2005 - 11/2004
2	Carrier Proteins (Binding Protein)IBA 08/2005 - 06/2004
2	Vitamin D FDA LinkGeneric 12/2002 - 01/2002
1	Cyclic AMP (AMP, Cyclic)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2021
1	Sodium-Potassium-Chloride SymportersIBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	RoflumilastIBA 01/2017
1	Cyclic NucleotidesIBA 01/2017
1	Phosphodiesterase InhibitorsIBA 01/2017
1	satavaptanIBA 02/2014
1	Neurophysins (Neurophysin I)IBA 02/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2011
1	Dinoprostone (PGE2)FDA Link 10/2009
1	K Cl- CotransportersIBA 02/2009
1	Contrast MediaIBA 11/2008
1	5-methoxy-methylindoleacetic acid (DBI)IBA 06/2008
1	ProstaglandinsIBA 04/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2008
1	Glucose (Dextrose)FDA LinkGeneric 12/2007
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 09/2007
1	Antihypertensive Agents (Antihypertensives)IBA 09/2007
1	Proton-Translocating ATPases (ATPase, H+)IBA 06/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	PotassiumIBA 06/2006
1	Dietary PotassiumIBA 06/2006
1	Lidocaine (Xylocaine)FDA LinkGeneric 04/2006
1	PlacebosIBA 04/2006

Therapy/Procedure

1	Ligation 12/2009